Sections
Shows
Events
US recommends ‘pause’ on administration of J&J's COVID-19 vaccine to investigate reports of blood clots
Johnson & Johnson’s COVID-19 vaccine differs considerably from Pfizer’s, Moderna’s
Biological E to produce 600 mn doses of Johnson & Johnson COVID-19 vaccine a year:
WHO recognises 'concerning news' of COVID-19 vaccines not working against variants
Some COVID-19 vaccine makers have declared their intentions to profit from the vaccine
Experts point out that the global distribution of a vaccine is necessary since none of us is safe until all of us are safe.
